OPGN Opgen Inc

OpGen Inc is an precision medicine company using molecular diagnostics and bioinformatics to help combat infectious disease.

As of 11/30/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  05/04/2015
Outstanding shares:  38,950,250
Average volume:  893,255
Market cap:   $61,541,395
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    68373L307
ISIN:        US68373L3078
Valuation   (See tab for details)
PE ratio:   -1.71
PB ratio:   1.77
PS ratio:   14.54
Return on equity:   -105.42%
Net income %:   -829.33%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy